Liang, JunZhou, HufengGerdt, CatherineTan, MinColson, TylerKaye, KennethKieff, ElliottZhao, Bo2019-10-142016Liang, Jun, Hufeng Zhou, Catherine Gerdt, Min Tan, Tyler Colson, Kenneth M. Kaye, Elliott Kieff, and Bo Zhao. 2016. “Epstein–Barr Virus Super-Enhancer ERNAs Are Essential for MYC Oncogene Expression and Lymphoblast Proliferation.” Proceedings of the National Academy of Sciences 113 (49): 14121–26. doi:10.1073/pnas.1616697113.0027-84240744-28311091-6490http://nrs.harvard.edu/urn-3:HUL.InstRepos:41543056Epstein-Barr virus (EBV) super-enhancers (ESEs) are essential for lymphoblastoid cell (LCL) growth and survival. Reanalyses of LCL global run-on sequencing (Gro-seq) data found abundant enhancer RNAs (eRNAs) being transcribed at ESEs. Inactivation of ESE components, EBV nuclear antigen 2 (EBNA2) and bromodomain-containing protein 4 (BRD4), significantly decreased eRNAs at ESEs -428 and -525 kb upstream of the MYC oncogene transcription start site (TSS). shRNA knockdown of the MYC -428 and -525 ESE eRNA caused LCL growth arrest and reduced cell growth. Furthermore, MYC ESE eRNA knockdown also significantly reduced MYC expression, ESE H3K27ac signals, and MYC ESEs looping to MYC TSS. These data indicate that ESE eRNAs strongly affect cell gene expression and enable LCL growth.en-USEpstein–Barr virus super-enhancer eRNAs are essential for MYC oncogene expression and lymphoblast proliferationJournal Article2019-10-1410.1073/pnas.1616697113